By Devika Patel
Knoxville, Tenn., Nov. 30 - NorDiag ASA said it has arranged a NOK 42 million private placement of shares.
The company will sell 42 million ordinary shares at NOK 1.00 per share.
The private placement will be managed by DnB NOR Markets.
NorDiag, based in Bergen, Norway, and in London, is a biotechnology company aiming to reduce mortality and treatment costs through detection of common cancers at the early, curable phases of cancer development.
| Issuer: | NorDiag ASA
|
| Issue: | Ordinary stock
|
| Amount: | NOK 42 million
|
| Shares: | 42 million
|
| Price: | NOK 1.00
|
| Warrants: | No
|
| Manager: | DnB NOR Markets
|
| Pricing date: | Nov. 30
|
| Stock symbol: | Oslo: NORD
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
